{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T13:17:48Z","timestamp":1649164668342},"reference-count":27,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2015,4,2]],"date-time":"2015-04-02T00:00:00Z","timestamp":1427932800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2015,4,2]],"date-time":"2015-04-02T00:00:00Z","timestamp":1427932800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacoepidemiol Drug Saf"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1002\/pds.3782","type":"journal-article","created":{"date-parts":[[2015,4,2]],"date-time":"2015-04-02T22:18:12Z","timestamp":1428013092000},"page":"1220-1224","source":"Crossref","is-referenced-by-count":2,"title":["Off-label use of nicardipine as tocolytic and acute pulmonary oedema: a post-marketing analysis of adverse drug reaction reports in EudraVigilance"],"prefix":"10.1002","volume":"24","author":[{"given":"Mauro","family":"Melis","sequence":"first","affiliation":[{"name":"Department of Medical and Surgical Sciences - Unit of Pharmacology; University of Bologna; Bologna Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amelia","family":"Cupelli","sequence":"additional","affiliation":[{"name":"Italian Medicines Agency (Agenzia Italiana del Farmaco, AIFA)Pharmacovigilance Office; Rome Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Sottosanti","sequence":"additional","affiliation":[{"name":"Italian Medicines Agency (Agenzia Italiana del Farmaco, AIFA)Pharmacovigilance Office; Rome Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Buccellato","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences - Unit of Pharmacology; University of Bologna; Bologna Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Biagi","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences - Unit of Pharmacology; University of Bologna; Bologna Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Vaccheri","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences - Unit of Pharmacology; University of Bologna; Bologna Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domenico","family":"Motola","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences - Unit of Pharmacology; University of Bologna; Bologna Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2015,4,2]]},"reference":[{"key":"10.1002\/pds.3782-BIB0001|pds3782-cit-0001","doi-asserted-by":"crossref","first-page":"e6226","DOI":"10.1136\/bmj.e6226","article-title":"Tocolytic therapy for preterm delivery: systematic review and network meta-analysis","volume":"345","author":"Haas","year":"2012 Oct 9","journal-title":"BMJ"},{"issue":"9","key":"10.1002\/pds.3782-BIB0002|pds3782-cit-0002","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.3109\/14767050903572182","article-title":"Safety concerns for the use of calcium channel blockers in pregnancy for the treatment of spontaneous preterm labour and hypertension: a systematic review and meta-regression analysis","volume":"23","author":"Khan","year":"2010 Sep","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1002\/pds.3782-BIB0003|pds3782-cit-0003","unstructured":"The pharmacological basis of therapeutics, eleventh edition (Italian) 2006 55 1509"},{"key":"10.1002\/pds.3782-BIB0004|pds3782-cit-0004","unstructured":"Atosiban EPAR summary http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/medicines\/human\/medicines\/002329\/human_med_001671.jsp&mid=WC0b01ac058001d124 2014"},{"key":"10.1002\/pds.3782-BIB0005|pds3782-cit-0005","unstructured":"Summary of Product Characteristics (SPC) - Miolene\u00ae tablets 2014"},{"key":"10.1002\/pds.3782-BIB0006|pds3782-cit-0006","unstructured":"PRAC recommendation http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Press_release\/2013\/10\/WC500153130.pdf 2014"},{"key":"10.1002\/pds.3782-BIB0007|pds3782-cit-0007","unstructured":"The Merck Manuals http:\/\/www.merckmanuals.com\/professional\/gynecology_and_obstetrics\/abnormalities_and_complications_of_labor_and_delivery\/preterm_labor.html 2014"},{"issue":"2","key":"10.1002\/pds.3782-BIB0008|pds3782-cit-0008","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ejogrb.2006.03.001","article-title":"Calcium channel blockers for tocolysis: a review of their role and safety following reports of serious adverse events","volume":"126","author":"Oei","year":"2006 Jun 1","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1002\/pds.3782-BIB0009|pds3782-cit-0009","unstructured":"Commission implementing regulation http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/regulation\/landing\/human_medicines_regulatory.jsp&mid 2014"},{"issue":"1","key":"10.1002\/pds.3782-BIB0010|pds3782-cit-0010","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ejogrb.2003.05.004","article-title":"Acute pulmonary oedema during nicardipine therapy for premature labour: report of five cases","volume":"113","author":"Vaast","year":"2004 Mar 15","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1002\/pds.3782-BIB0011|pds3782-cit-0011","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/242703","article-title":"Nicardipine-induced acute pulmonary edema: a rare but severe complication of tocolysis","author":"Serena","year":"2014","journal-title":"Case Reports in Critical Care"},{"key":"10.1002\/pds.3782-BIB0012|pds3782-cit-0012","unstructured":"EudraVigilance https:\/\/eudravigilance.ema.europa.eu\/highres.htm 2014"},{"key":"10.1002\/pds.3782-BIB0013|pds3782-cit-0013","unstructured":"EMA working instructions http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Work_Instruction_-_WIN\/2012\/09\/WC500132805.pdf 2014"},{"key":"10.1002\/pds.3782-BIB0014|pds3782-cit-0014","unstructured":"Guideline on the use of statistical signal detection methods in the EudraVigilance data analysis system http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Regulatory_and_procedural_guideline\/2009\/11\/WC500011434.pdf 2014"},{"key":"10.1002\/pds.3782-BIB0015|pds3782-cit-0015","unstructured":"Guideline on good pharmacovigilance practices http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2012\/06\/WC500129138.pdf 2014"},{"issue":"2","key":"10.1002\/pds.3782-BIB0016|pds3782-cit-0016","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981 Aug","journal-title":"Clin Pharmacol Ther"},{"issue":"Suppl 1","key":"10.1002\/pds.3782-BIB0017|pds3782-cit-0017","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1471-0528.2005.00591.x","article-title":"Nifedipine trials: effectiveness and safety aspects","volume":"112","author":"Van Geijn","year":"2005 Mar","journal-title":"BJOG"},{"issue":"6","key":"10.1002\/pds.3782-BIB0018|pds3782-cit-0018","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.jgyn.2010.04.004","article-title":"Nifedipine or nicardipine in management of threatened preterm delivery: an observational population-based study","volume":"39","author":"Le Ray","year":"2010 Oct","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"key":"10.1002\/pds.3782-BIB0019|pds3782-cit-0019","unstructured":"SPC Loxen http:\/\/base-donnees-publique.medicaments.gouv.fr\/ 2014"},{"key":"10.1002\/pds.3782-BIB0020|pds3782-cit-0020","unstructured":"National French College of Gynecologists and Obstetricians (CNGOF) http:\/\/www.cngof.asso.fr\/d_livres\/2001_go_183_tsatsaris.pdf 2014"},{"key":"10.1002\/pds.3782-BIB0021|pds3782-cit-0021","unstructured":"Royal College of Obstetricians and Gynaecologists (RCOG) Tocolysis for women in preterm labour 2011"},{"issue":"Suppl 3","key":"10.1002\/pds.3782-BIB0022|pds3782-cit-0022","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/BF00051613","article-title":"Pharmacological aspects of calcium channel blockers","volume":"10","author":"Scholz","year":"1997 Jan","journal-title":"Cardiovasc Drugs Ther"},{"issue":"6","key":"10.1002\/pds.3782-BIB0023|pds3782-cit-0023","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1111\/j.1365-2125.2011.04037.x","article-title":"Benefits and strengths of the disproportionality analysis for identification of adverse drug reactions in a pharmacovigilance database","volume":"72","author":"Montastruc","year":"2011 Dec","journal-title":"Br J Clin Pharmacol"},{"key":"10.1002\/pds.3782-BIB0024|pds3782-cit-0024","unstructured":"European database of suspected ADR reports http:\/\/www.adrreports.eu 2014"},{"key":"10.1002\/pds.3782-BIB0025|pds3782-cit-0025","unstructured":"Drugcite http:\/\/www.drugcite.com\/?q=nicardipine 2014"},{"key":"10.1002\/pds.3782-BIB0026|pds3782-cit-0026","unstructured":"Pharmacovigilance Risk Assessment Committee PRAC recommendations on signals http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/PRAC_recommendation_1 on_sign 2 al\/2013\/10\/WC500150866.pdf 2015"},{"key":"10.1002\/pds.3782-BIB0027|pds3782-cit-0027","unstructured":"European Medicines Agency gives recommendations on the use of intravenous nicardipine http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Press_release\/2013\/10\/WC50015 3122.pdf 2014"}],"container-title":["Pharmacoepidemiology and Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpds.3782","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpds.3782","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/pds.3782\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T23:43:26Z","timestamp":1625355806000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pds.3782"}},"subtitle":["OFF-label use of nicardipine"],"short-title":[],"issued":{"date-parts":[[2015,4,2]]},"references-count":27,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11]]}},"URL":"https:\/\/doi.org\/10.1002\/pds.3782","archive":["Portico"],"relation":{},"ISSN":["1053-8569"],"issn-type":[{"value":"1053-8569","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4,2]]}}}